Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
Roman V. Petrov, MD, PhD
lungcanc
Gideon M. Blumenthal, MD
lungcanc
Q&A with Alice Shaw, MD, PhD
lungcanc
Q&A with Benjamin Solomon, MBBS, PhD, FRACP
lungcanc
Comments on the 8th Edition of the TNM Classification of Lung...
lungcanc
IASLC Workshop in Lung Cancer Clinical Research
lungcanc
Robert L. Comis, MD
lungcanc
World No-Tobacco Day 2017: Women Against Lung Cancer in Europe’s European...
lungcanc
Changing Treatment Paradigm for ALK-Positive Lung Cancer
lungcanc
Prof. Nir Peled, MD, PhD, FCCP
lungcanc
1
...
35
36
37
...
53
Page 36 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
